An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa

BACKGROUND: Global ambitions to eliminate malaria are intensifying, underscoring a critical need for transmission blocking tools. In 2012, the WHO recommended the use of 0.25 mg/kg of single low-dose (SLD) primaquine to stop Plasmodium falciparum transmission. To ensure the availability of SLD prima...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Malar J
Päätekijät: Chen, Ingrid, Poirot, Eugenie, Newman, Mark, Kandula, Deepika, Shah, Renee, Hwang, Jimee, Cohen, Justin M., Gosling, Roly, Rooney, Luke
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446184/
https://ncbi.nlm.nih.gov/pubmed/25971688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0714-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia